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Abstract
Macrophage migration inhibitory factor (MIF) is a pluripotent factor produced by a variety of cells. It plays an important
biological role in the regulation of pregnancy and has been shown to influence malaria pathogenesis. In this study, the
levels of MIF in the peripheral, cord and placental intervillous blood (IVB) plasma collected from women residing in a malaria
endemic region of Central India was determined and its association with malaria in pregnancy and birth outcomes was
investigated. MIF levels were significantly different in IVB, peripheral, and cord plasma, with IVB plasma having the highest
MIF levels and peripheral plasma having the lowest. Placental malaria positive women had significantly higher IVB plasma
MIF levels than placental malaria negative women, but this relationship was not seen in peripheral or cord plasma MIF
levels. In addition, the odds of stillbirth and low birth weight deliveries for the uppermost placental MIF quartile (irrespective
of placental malaria status) was significantly higher than that of the lowest placental MIF quartile, supporting the hypothesis
that elevated concentrations of placental MIF may be associated with an increased risk of adverse birth outcome.
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Introduction
A hallmark of malaria during pregnancy is the sequestration of
malaria-infected red blood cells (iRBCs) containing late develop-
mental stages of malaria parasite such as late trophozoite and early
schizonts in the intervillous spaces (IVS) of the placenta [1,2]. This
is usually accompanied by the infiltration of maternal leukocytes,
especially monocytes, in the IVS [3,4] and hemozoin deposition
[1,5], resulting in what is referred to as placental malaria (PM).
PM poses substantial risk for poor fetal outcomes such as low birth
weight (LBW), prematurity and stillbirths, as reviewed in [6]. A lot
of what is known about malaria in pregnancy comes from studies
conducted in Africa. Although the prevalence of malaria in
pregnant Indian women is lower than the prevalence in African
women [7,8], several epidemiological studies have demonstrated
that malaria in pregnancy is a public health problem in India as
well [8–14,15,16]. In India, commonly observed complications
due to malaria in pregnancy include many of the same
complications observed in African settings, namely preterm
deliveries, intra uterine death, LBW, stillbirths and abortions [16].
The immunological consequences of malaria in pregnancy have
been widely investigated. Several studies have demonstrated the
presence of both proinflammatory and anti-inflammatory immune
factors in malaria-infected placentas [17–23]. However, while
proinflammatory responses are important for the clearance of
iRBCs and for the protection against PM, they have also been
shown to play a role in malaria pathophysiology and to contribute
to morbidity associated with malaria in pregnancy [24]. These
proinflammatory immune responses have been associated with the
ensuing monocytic infiltration [3,21] which has been associated
with poor fetal outcomes [3,4,25]. Of interest in pregnancy and
pregnancy-associated infections is the immune factor macrophage
migration inhibitory factor (MIF), a proinflammatory cytokine
involved in physiological and pathological processes in pregnancy.
MIF is a pluripotent cytokine produced by a variety of normal cell
types and tissues, including macrophages, monocytes, endocrine
glands and reproductive organs [26]. MIF is capable of inhibiting
the random migration of mononuclear cells and of circumventing
the effects of glucocorticoid-mediated immunosuppression often
observed in pregnancy. MIF was shown to be highly elevated in
the placenta of pregnant women with malaria [23,27] and other
intrauterine infections [28] and in peripheral serum of women
with preeclampsia [29,30]. While MIF plays a major role in
normal pregnancy, delivery and even labor [31,32], increased
levels of amniotic fluid MIF [28] and peripheral serum MIF [33]
were shown to be associated with preterm labor. Given that
elevated MIF levels have been observed in women with PM,
determining whether or not MIF contributes to the poor fetal
outcomes associated with PM is of interest.
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In this study, we investigated the relationship between MIF
levels in IVB, peripheral, and cord plasma samples in pregnant
women residing in a low transmission setting in Central India. We
also compared MIF levels for PM+ and PM- women and
investigated the relationship between MIF and adverse outcomes
associated with P. falciparum infection.
Materials and Methods
Study Site and Sampling Method
This study was carried out between July 2008 and December
2009 in the delivery unit at Civil Hospital, Maihar, India. This is a
secondary health facility that caters to the health needs of rural,
semi-urban and ethnic tribal population of Central India. This
study was approved by the ethical research committee of Regional
Medical Research Center for Tribals, Jabalpur, India, and the
Centers for Disease Control and Prevention, Atlanta, GA, USA.
Pregnant women who presented at the delivery unit were screened
for malaria by microscopic examination of a peripheral blood
smear. Figure 1 summarizes the sampling process in this study. A
total of 4299 women were screened, and women over the age of 18
with no chronic disease were invited to participate in the study. By
microscopy, 47 women were found to have P. falciparum infection
in both placental and peripheral blood (Figure 1), and these were
included in the study as the placental malaria positive cases (PM+).
All 485 women whose peripheral and placental smears were
malaria negative could not be enrolled in the study due to
budgetary constraints, so a subset of 122 was selected to be in the
placental malaria negative (PM- control group). The PM- group
was chosen so that it would have approximately the same
percentage of LBW babies, the same percentage of stillbirths,
and the same gravidity distribution as the PM+ women. The
purpose of the study was described to all the participants who were
enrolled only after obtaining written consent. All consent forms
were kept at Regional Medical Research Centre for Tribals,
Jabalpur, India.
Sample Collection
Upon enrollment, socioeconomic status, fever history, clinical
symptoms, hemoglobin and auxiliary temperature were recorded
for each woman. Peripheral blood smears (thick and thin) were
taken for malaria parasite examination and about 1 ml of
peripheral blood was collected for immunological study. After
delivery, the expelled placenta was collected and processed for
intervillous blood (IVB) and cord blood collection. The IVB was
collected using the incision method [1]; two to three shallow cuts
approximately 2 mm deep were made into the maternal surface of
the placenta’s third quadrant using a sterile scalpel. About one ml
of placental blood that seeped into these incisions was collected
using a blunt 1-ml syringe and transferred into a heparinized
microcentrifuge tube. Cord blood was taken by manual compres-
sion of the umbilical cord. Subsequently, placental blood smear,
tissue impression smear and cord blood smear were prepared for
malaria parasite examination. Plasma was prepared from periph-
eral, IVB and cord blood and was stored in 280uC until used for
experiments. The blood films were stained with Giemsa and
examined by an experienced technician in the field laboratory
using an oil-immersion lens (1006magnification). The technician
examined 100 microscopic field of thick smear before declaring a
smear as negative [34]. All blood films were read twice by different
microscopists at a reference laboratory. Discordant results were
given a third reading by a microscopist blinded to the results of the
first two readings, the result of which was considered as final.
Histological examination of the placenta was not performed.
Birth Outcomes
A baby born with no sign of life at or after 28 weeks of gestation
was considered a stillbirth. Live birth was defined as complete
expulsion of a live baby, irrespective of the duration of the
pregnancy. Babies with birth weight below 2500 grams were
considered LBW babies, and other babies were considered to have
normal birth weight (NBW). Note that birth weight was not
measured for stillbirths.
MIF Level Estimation
The levels of MIF in IVB, peripheral and cord blood plasma
were measured by a standard enzyme-linked immunosorbent
assay (ELISA) using a commercially available kit (R&D Duoset,
Minneapolis, MN) as previously describes [23].
Statistical Analysis
Mother characteristics and birth outcomes were compared for
PM+ and PM2 women. Chi-square tests were used to compare
PM groups in terms of categorical variables, and t-tests were used
for continuous variables since these variables did not strongly
deviate from normality. Since MIF levels were highly skewed, the
log MIF levels were used in linear models with MIF as the
outcome. Log MIF levels for IVB, peripheral, and cord plasma
samples were compared using a linear mixed model, allowing
measurements from the same mother to be correlated. Another
linear mixed model was used to compare log MIF levels of PM+
and PM2 women. A PM status by plasma type (IVB, peripheral,
or cord) interaction was included initially so that it could be
determined whether or not the difference in log MIF level varied
by plasma type. Like the model for plasma type, this model
allowed measurements from the same mother to be correlated.
Hemoglobin level, maternal age, auxiliary temperature, plasma
type, and gravidity were controlled for in the PM model.
Logistic regression was used to investigate the relationship
between IVB plasma MIF levels and birth outcomes. Since odds
ratios for birth outcomes did not appear to have a linear
association with log MIF levels, quartiles were used to define
MIF categories, and odds ratios were calculated for the three
upper quartiles using the lowest quartile as the reference. The
model for the stillbirth outcome controlled for PM status,
hemoglobin level, maternal age, auxiliary temperature, and
gravidity. For the LBW outcome, stillbirths were excluded, and
the model controlled for PM status, hemoglobin level, maternal
age, auxiliary temperature, gestational age, and gravidity. All
statistical analyses were performed using SAS v. 9.3 (SAS Institute
Inc., Cary, NC, USA).
Results
Patient Characteristics
A total of 169 women (47 PM+ and 122 PM2) were enrolled
into the study. Of these, 63 were primigravidae (first pregnancy),
30 secundigravidae (second pregnancy) and 76 were multigravidae
(more than two previous pregnancies). Since PM2 and PM+
groups were matched in terms of birth weight, stillbirths, and
gravidity, these variables did not and were not expected to differ
between the two groups. As summarized in Table 1, PM+ women
had significantly higher body temperature and were more anemic
than PM2 women.
MIF Level in IVB, Cord and Peripheral Plasma
MIF was detected in 169 IVB samples, 167 of the peripheral
samples and in 63 of the cord samples. Several reasons contributed
to the missing cord samples: stillbirth deliveries (24 cases),
High IVB MIF Levels and Adverse Birth Outcomes
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caesarean delivery (34 cases), retained placenta (22 cases), post
partum haemorrhage (13 cases) and delayed collection of placenta
(13 cases). As shown in Figure 2, means of log MIF levels were
significantly different for the three plasma types (p,0.001 for all
pairwise comparisons), with IVB plasma having the highest log
MIF level, followed by cord and peripheral samples.
Elevated IVB MIF in PM Positive Women
Analysis revealed that the mean log MIF level was significantly
higher in PM+ women compared to PM2 women when
controlling for possible confounders (Table 1) (difference of 0.39;
CI 0.16–0.63; p = 0.001). There was no significant difference in
the peripheral and cord MIF levels based on infection malaria
infection status.
Effects of MIF on Delivery Outcomes
For the stillbirth outcome, the odds ratio for the uppermost MIF
quartile versus the lowest MIF quartile was found to be significant,
meaning that the odds of having a low birth weight baby was
elevated in the highest MIF category when compared to the lowest
MIF category (OR 5.06; 95% CI 1.65 to 15.53; p = 0.005). The
odds of the adverse birth outcomes did not differ for the other two
MIF quartiles when compared to the lowest MIF quartile. In the
model for LBW, a similar relationship was seen between the
uppermost MIF quartile and the lowest (OR 9.09; 95% CI 1.96 to
42.21; p = 0.005) (Table 2). Overall, these associations were
evident irrespective of placental malaria infection status.
Discussion
A previous study by Chaisavaneeyakorn et al. reported signif-
icantly elevated MIF levels in the IVB plasma of Kenyan pregnant
women compared to both peripheral and cord plasma [23].
Similar results were obtained by Chaiyaroj et al., who observed
significantly higher MIF production by intervillous blood mono-
nuclear cells (IVBMC) compared to peripheral blood mononucle-
ar cells (PBMC), as well as high MIF level in placental plasma
compared to paired peripheral plasma [27]. Our finding confirms
this observation in an Indian population as MIF was shown to be
present at very high levels in the IVB plasma as compared with
peripheral and cord plasma. This finding is not surprising given
that MIF has been shown to play important roles during normal
pregnancy [31,32] and therefore, IVB MIF would be expected to
be high.
We observed significantly higher IVB MIF levels in women with
PM compared to PM2 women. Similar findings were reported by
Chaisavaneeyakorn et al. who suggested that MIF may play a role
in the pathogenesis of malaria [23]. MIF is a pluripotent immune
factor known to regulate both innate and adaptive immune
responses to bacterial and parasitic infections. Several studies have
demonstrated elevated levels of MIF in the peripheral or placental
blood during malaria infections [23,35–37]. MIF was shown to be
induced in response to P. chabaudi infection in mice and was
implicated in the pathogenesis of malaria anemia [35]. Awandare
et al. suggested that reduced MIF production may promote
enhanced disease severity in children with P. falciparum malaria
Figure 1. Schematic flow chart summarizing the sampling process. A total of 4299 women were screened for this study. Forty seven women
positive for P. falciparum infection in both placental and peripheral blood by microscopy were enrolled into the study (PM+ cases). Out of the 485
women who had no malaria parasite in the peripheral as well as placental smear, 122 were selected and included as healthy controls (PM-group).
doi:10.1371/journal.pone.0051678.g001
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[36], implying that MIF may be required to clear a malaria
infection. One of the roles of MIF is to inhibit the random
migration of macrophages which has been demonstrated in vitro
[38]. We hypothesize that the increased MIF levels found in the
placenta of malaria positive women is induced by the malaria
parasites which tend to accumulate in the placenta [3,21] and that
this may help to retain macrophages in the placenta. MIF,
together with other proinflammatory factors such as IFN-c and
TNF-a, may then activate these macrophages to clear and kill
malaria parasites in the placenta.
It is generally accepted that about 50% or more of stillbirths in
low and middle income countries are caused by maternal
intrauterine infections (reviewed in [39]). It has also been
suggested that excessive proinflammatory immune responses
may lead to adverse placental pathophysiology. These proin-
flammatory immune responses have been associated with the
ensuing monocytic infiltration [3,21] observed in malaria infected
placentas and which has been associated with poor fetal outcomes
such as LBW [3,4,25]. In this study, higher levels of IVB MIF were
associated with stillbirth deliveries and LBW babies irrespective of
malaria infection status. To our knowledge, this is one of the first
reports to demonstrate an association between elevated placental
MIF levels and poor birth outcomes. Previous studies have shown
that maternal peripheral serum MIF is associated with preterm
delivery [40] and preeclampsia [30]. Two different explanations
can be considered for the current findings. One possibility is that
elevated levels of MIF may directly regulate some biological events
related to stillbirth and LBW. For example, high levels of MIF
(along with other factors such as TNF) can activate the inducible
cyclooxygenase (COX)-2 pathway, leading to higher prostaglandin
production and potentially other pathways that contribute to
stillbirth and LBW. MIF was shown to directly stimulate the
synthesis of COX-2 and the release of prostaglandin E2 in ectopic
endometrial cells [41]. Increased levels of prostaglandin E2 and
prostaglandin F2a induced by alcohol were shown to cause fetal
death [42]. Therefore, MIF may have a direct role in activating
biological pathways that contribute to stillbirths and LBW. The
second possibility is that elevated levels of MIF may be simply a
marker for proinflammatory events occurring in the IVB and
Table 1. Mother characteristics and birth outcomes by placental malaria status.
Malaria Positive{ Malaria Negative{ P Value**
(N = 47) (N = 122)
Characteristics of Mothers
Average age (years) 25.263.9 25.163.9 0.87
Auxiliary Temperature (uC ) 37.061.1 35.961.4 ,0.001
Mean Hemoglobin (g/dl) 10.162.1 11.562.4 ,0.001
Anemia % (,11 g/dl) 32 (68%) 49 (40%) 0.001
Gravidity*
Primigravid 22 (47%) 41 (34%) 0.25
Secundigravid 6 (13%) 24 (20%)
Multigravid 19 (40%) 57 (47%)
Log MIF
IVB Plasma 8.4360.95 7.9760.78 0.001
Peripheral Plasma{ 2.7661.21 2.3760.84 0.051
Cord Plasma{ 5.4661.16 5.0361.30 0.22
Birth Outcomes
Baby Birth Weight (g) { 2324.16452.9 2440.46413.2 0.16
Low Birth Weight (n)*{ 22 (59%) 56 (57%) 0.76
Stillbirth (n)* 10 (21%) 23 (19%) 0.72
*Indicates variable used to frequency match PM+ and PM2 groups.
**P-values reported are from Pearson chi-square test for categorical variables and two-sample t-test for continuous variables.
{Numbers reported are mean 6 standard deviation for continuous variables and n (%) for categorical variables.
{Birth weight information was collected for 37 babies born to PM+ women and 99 babies born to PM2 women (birth weight was not collected for stillbirths).
Peripheral plasma samples were available for 47 PM+ women and all 122 PM2 women.
Cord plasma samples were available for 20 PM+ women 43 PM2 women.
Note that all PM+ and PM2 women had IVB plasma samples available.
doi:10.1371/journal.pone.0051678.t001
Figure 2. Elevated MIF levels observed in IVB plasma. The IVB,
peripheral, and cord plasma log MIF levels were significantly different
from one another (p,0.001). Horizontal bars indicate mean of log MIF
+/2 SD.
doi:10.1371/journal.pone.0051678.g002
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therefore, simply serve as a predictor of the events leading to the
poor outcomes. A proinflammatory milieu is commonly observed
in malaria infected placentas and this has been associated with
poor fetal outcomes such as LBW [3,4,25]. It is not surprising that
this association was evident irrespective of placental malaria
infection status because the elevated levels of MIF can occur due
to many infectious agents and once MIF is activated beyond a
particular threshold it is likely to trigger biological pathways that
contribute to poor birth outcomes.
LBW is a hallmark of malaria during pregnancy with several
studies demonstrating an increase in LBW babies delivered by
PM+ women compared to PM- women. [3,4,25,43,44]. A caveat
of this study is the fact that we could not test for any differences in
birth weight in these two groups since the percentage of low birth
weight of infants born to PM2 women was matched to that of
PM+ women in the selection process. Therefore, the apparent lack
of differences in birth weight in this study (mean birth weight
,2500 g) is due to an enrolment artefact and might not have any
generalizable bearing to this population.
In conclusion, this study demonstrates that intervillous MIF is
significantly elevated in the presence of placental malaria. In
addition, elevated intervillous MIF levels are associated with both
stillbirth and low birth weight deliveries.
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